Predictors of Self-Reported Adherence and Plasma HIV Concentrations in Patients on Multidrug Antiretroviral Regimens
Top Cited Papers
- 1 April 2000
- journal article
- research article
- Published by Wolters Kluwer Health in JAIDS Journal of Acquired Immune Deficiency Syndromes
- Vol. 23 (5), 386-395
- https://doi.org/10.1097/00126334-200004150-00005
Abstract
Summary:To examine influences of medical factors (e.g., viral load) and nonmedical factors (e.g., patient characteristics) on treatment decisions for highly active antiret-roviral therapy (HAART), we sent a survey to a random sample of 995 infectious disease physicians who treat patients with HIV/AIDS in the United States in August, 1998. The response rate was 53%. Respondents were asked to report their current practices with respect to antiretroviral treatment and the extent to which each of three medical and 17 nonmedical factors would influence them for or against prescribing HAART to a hypothetical HIV-positive patient. Most reported initiating HAART with findings of low CD4+ cell counts and high viral loads, and weighing CD4+ cell counts, viral load, and opportunistic infection heavily in their decisions to prescribe HAART. Patients' prior history of poor adherence was weighed very much against initiating HAART. Patient homelessness, heavy alcohol use, injection drug use, and prior psychiatric hospitalization were cited by most physicians as weighing against HAART initiation. Thus, most physicians in this sample follow guidelines for the use of HAART, and nonmedical factors related to patients' life situations are weighed as heavily as disease severity in treatment decisions. As HIV increasingly becomes a disease associated with economic disadvantage and other social health problems, it will be essential to develop interventions and care support systems to enable patients experiencing these problems to benefit from HIV treatment advances. Address correspondence and reprint requests to Laura M. Bogart, Department of Psychology, 118 Kent Hall, Kent State University, Kent, OH 44242-0001, U.S.A.; email: [email protected] Manuscript received November 24, 1999; accepted February 16, 2000. © 2000 Lippincott Williams & Wilkins, Inc.Keywords
This publication has 40 references indexed in Scilit:
- Adherence of Human Immunodeficiency Virus–Infected Patients to Antiretroviral TherapyClinical Infectious Diseases, 1999
- The value of patient-reported adherence to antiretroviral therapy in predicting virologic and immunologic responseAIDS, 1999
- Characterizing patterns of drug-taking behavior with a multiple drug regimen in an AIDS clinical trialAIDS, 1998
- A Randomized Trial of Three Maintenance Regimens Given after Three Months of Induction Therapy with Zidovudine, Lamivudine, and Indinavir in Previously Untreated HIV-1–Infected PatientsNew England Journal of Medicine, 1998
- Maintenance Antiretroviral Therapies in HIV-Infected Subjects with Undetectable Plasma HIV RNA after Triple-Drug TherapyNew England Journal of Medicine, 1998
- Maintenance therapy after quadruple induction therapy in HIV-1 infected individuals: Amsterdam Duration of Antiretroviral Medication (ADAM) studyThe Lancet, 1998
- A Randomized, Double-blind Trial Comparing Combinations of Nevirapine, Didanosine, and Zidovudine for HIV-Infected PatientsJAMA, 1998
- Collaborative Management of Chronic IllnessAnnals of Internal Medicine, 1997
- Compliance with treatment regimens in chronic asymptomatic diseasesThe American Journal of Medicine, 1997
- Patients’ participation in medical careJournal of General Internal Medicine, 1988